Literature DB >> 12509624

Elevated plasma concentrations of nitric oxide, soluble thrombomodulin and soluble vascular cell adhesion molecule-1 in patients with systemic lupus erythematosus.

C Y Ho1, C K Wong, E K Li, L S Tam, C W K Lam.   

Abstract

OBJECTIVE: To investigate the correlations among plasma concentrations of nitric oxide (NO), soluble thrombomodulin (sTM) and vascular cell adhesion molecule (sVCAM-1), and whether these three molecules are associated with renal involvement in patients with systemic lupus erythematosus (SLE).
METHODS: Plasma NO concentrations of 73 SLE patients (35 with renal disease, RSLE patients; 38 without renal disease, SLE patients) and 28 age- and sex-matched healthy control subjects were measured by the non-enzymatic Griess assay, and sTM and sVCAM-1 by enzyme-linked immunosorbent assay.
RESULTS: In RSLE patients, plasma nitrite concentrations were significantly higher than in control subjects (P=0.009) and correlated positively with plasma sTM, plasma creatinine and urea (all P<0.05). Plasma sTM and sVCAM-1 concentrations were significantly elevated in RSLE and SLE patients (both P<0.0001) compared with controls. Plasma sTM was significantly correlated with plasma sVCAM-1, and both were correlated with plasma creatinine and urea and the SLE Disease Activity Index (all P<0.05).
CONCLUSION: Elevated plasma NO, sTM, and sVCAM-1 concentrations have significant intercorrelations and are strongly associated with renal involvement in SLE.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12509624     DOI: 10.1093/rheumatology/keg045

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  15 in total

Review 1.  Biomarkers in systemic lupus erythematosus.

Authors:  Gabor G Illei; Peter E Lipsky
Journal:  Curr Rheumatol Rep       Date:  2004-10       Impact factor: 4.592

2.  Thrombomodulin Protects Against Bacterial Keratitis, Is Anti-Inflammatory, but Not Angiogenic.

Authors:  Sharon A McClellan; Sandamali A Ekanayaka; Cui Li; Xiaoyu Jiang; Ronald P Barrett; Linda D Hazlett
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

3.  Role of long non-coding RNAs expression (ANRIL, NOS3-AS, and APOA1-AS) in development of atherosclerosis in Egyptian systemic lupus erythematosus patients.

Authors:  Mai A Abd-Elmawla; Mary Wadie Fawzy; Sherine M Rizk; Amira A Shaheen
Journal:  Clin Rheumatol       Date:  2018-08-21       Impact factor: 2.980

4.  The levels of sCD30 and of sCD40L in a group of patients with systemic lupus erythematodes and their diagnostic value.

Authors:  Hana Ciferská; Pavel Horák; Zuzana Hermanová; Marta Ordeltová; Josef Zadrazil; Tomás Tichý; Vlastimil Scudla
Journal:  Clin Rheumatol       Date:  2006-11-14       Impact factor: 2.980

5.  Endothelial Activation Markers as Disease Activity and Damage Measures in Juvenile Dermatomyositis.

Authors:  Takayuki Kishi; Jonathan Chipman; Melvina Evereklian; Khanh Nghiem; Maryalice Stetler-Stevenson; Margaret E Rick; Michael Centola; Frederick W Miller; Lisa G Rider
Journal:  J Rheumatol       Date:  2019-08-01       Impact factor: 4.666

6.  Endothelial cell markers reflecting endothelial cell dysfunction in patients with mixed connective tissue disease.

Authors:  Pal Soltesz; Daniel Bereczki; Peter Szodoray; Maria T Magyar; Henrietta Der; Istvan Csipo; Agota Hajas; Gyorgy Paragh; Gyula Szegedi; Edit Bodolay
Journal:  Arthritis Res Ther       Date:  2010-05-06       Impact factor: 5.156

7.  Immunosuppressive therapy modulates T lymphocyte gene expression in patients with systemic lupus erythematosus.

Authors:  Elayne Pereira; Márcia Cristina Tamia-Ferreira; Renato Sousa Cardoso; Stephano Spanó Mello; Elza Tiemi Sakamoto-Hojo; Geraldo A S Passos; Eduardo Antonio Donadi
Journal:  Immunology       Date:  2004-09       Impact factor: 7.397

8.  Association of serum nitrate and nitrite levels with longitudinal assessments of disease activity and damage in systemic lupus erythematosus and lupus nephritis.

Authors:  Jim C Oates; Stephanie R Shaftman; Sally E Self; Gary S Gilkeson
Journal:  Arthritis Rheum       Date:  2008-01

9.  Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvement.

Authors:  Anna Kuryliszyn-Moskal; Piotr Adrian Klimiuk; Stanislaw Sierakowski
Journal:  Clin Rheumatol       Date:  2004-09-03       Impact factor: 2.980

10.  Decreased plasma soluble thrombomodulin levels as a risk factor for pulmonary thromboembolism.

Authors:  Yu-Dong Yin; Chen Wang; Zhen-Guo Zhai; Bao-Sen Pang; Yuan-Hua Yang; Xiu-Xia Huang
Journal:  J Thromb Thrombolysis       Date:  2008-03-31       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.